Photo Credit: COURTESY IMAGE
In a potential game changer for the treatment of superbugs, a new class of antibiotics was developed that cured mice infected with bacteria deemed nearly “untreatable” in humans — and resistance to the drug was virtually undetectable.
Developed by a research team of UC Santa Barbara scientists, the study was published(link is external) in the journal eBioMedicine. The drug works by disrupting many bacterial functions simultaneously — which may explain how it killed every pathogen tested and why low-level of bacterial resistance was observed after prolonged drug exposure.
The project was led by professors Michael Mahan, David Low, Chuck Samuel and their research team, Douglas Heithoff, Scott Mahan, Lucien Barnes and Cyril George. Additional contributors include professors Guillermo Bazan (UC Santa Barbara) and Andrei Osterman (Sanford Burnham Prebys Medical Discovery Institute).
The discovery was serendipitous. The U.S. Army had a pressing need to charge cell phones while in the field — essential for soldier survival. Because bacteria are miniature power plants, compounds were designed by Bazan’s group to harness bacterial energy as a “microbial” battery. Later the idea arose to re-purpose these compounds as potential antibiotics.
“When asked to determine if the chemical compounds could serve as antibiotics, we thought they would be highly toxic to human cells similar to bleach,” said Mahan, the project lead. “Most were toxic — but one was not — and it could kill every bacterial pathogen we tested.”
What makes the drug unique is the failure of bacteria to become resistant to it. And bacterial resistance is typically a major barrier to antibiotic development since it limits a drug’s (potential value in the marketplace.
“The key finding was that bacterial resistance to the drug was virtually undetectable,” said lead author Heithoff. “Most drugs fail at this stage of development and never get to clinical practice.”
The antibiotic has a unique mechanism of action. Contrary to most drugs (like penicillin) that target a specific germ function, the new drug targets many functions simultaneously.
“The drug appears to affect the bacterial membrane which, in turn, disrupts multiple bacterial functions,” explained Low, the co-project lead. “This may account for the broad-spectrum antibacterial activity and low level of bacterial resistance.”
“This class of antibiotics has potential as a new versatile therapy for antimicrobial resistant pathogens,” Samuel said.
Additional drug safety and efficacy studies will need to be conducted to fully understand the clinical benefits and risks before the drug can be used in clinical practice.
Original Article: Resistance Is Futile
More from: University of California Santa Barbara | Sanford Burnham Prebys Medical Discovery Institute
The Latest Updates from Bing News
Go deeper with Bing News on:
Superbugs
- Duke doctor: Superbugs are the next pandemic. What the US must do to combat them.
By Dr. Vance Fowler Superbugs kill an estimated 700,000 people worldwide each year. A Duke University infectious disease specialist says one promising policy solution is the PASTEUR Act ...
- Monash University-led Project Bioprospecting Viruses That Can Kill Deadly Superbugs
In a modern take on the Victorian gold rush, a Monash University-led project is successfully ‘bioprospecting’ for viruses known as phages that can kill deadly superbugs.The Monash Biomedicine ...
- How researchers used AI to find an antibiotic against a superbug
Superbugs are bacteria that are resistant to several types of antibiotics. Each year these drug-resistant bacteria infect more than 2 million people in the US and kill at least 23,000, according to ...
- Superbugs will struggle to evolve resistance to unusual new antibiotic
A much-needed new kind of antibiotic can kill bacteria such as MRSA and works in a way that makes it extremely difficult for resistance to evolve ...
- Millions of people are battling superbugs. What happens when the drugs don’t work?
They could wipe 20 years off average life expectancy and rock the foundations of modern medicine. What are superbugs? What can we do about them?
Go deeper with Bing News on:
New class of antibiotics
- Medicare will require research registry for coverage new Alzheimer’s drugs
The Centers for Medicare and Medicaid Services says it will cover a new class of drugs meant to treat the early stages of Alzheimer’s disease in the brain.
- Finally, a promising new class of drugs is making its way to Alzheimer’s patients
At last: a glimmer of hope on the horizon. After decades of frustration and failure, including a spectacular misfire by one of the state’s biotech pillars, the first medicines to slow cognitive ...
- New rule prevents farmers from buying many over-the-counter drugs for their animals
Officials say restricting antibiotic use in livestock is one step to slow the process of increasing antibiotic resistance.
- TMC207: The First Compound of a New Class of Potent Anti-tuberculosis Drugs
The ability of a single anti-TB drug to rapidly reduce the bacillary load (EBA) is an important aspect to be considered when testing a new TB drug since it is linked to the duration of ...
- Medicare Will Cover New Class of Alzheimer Drugs if Fully Approved by FDA, With Limits
Medicare will soon cover a new class of drugs for Alzheimer disease if they receive full approval from the U.S. Food and Drug ...
